ClinicalTrials.Veeva

Menu

Athlete's Heart or Arrhythmogenic Right Ventricular Cardiomyopathy: Contribution of Exercise Cardiovascular Magnetic Resonance (CMR) (CA2VD)

R

Rennes University Hospital

Status

Enrolling

Conditions

Arrhythmogenic Right Ventricular Cardiomyopathy

Treatments

Other: Cardiac exercises and tests

Study type

Interventional

Funder types

Other

Identifiers

NCT05024708
35RC21_9886_CA2VD

Details and patient eligibility

About

Prospective, nonrandomized, single-center, comparative study to define if right ventricular (RV) contractile reserve assessed by exercise CMR helps to improve the differential diagnosis between pathological and physiological remodeling of the RV; ie. arrhythmogenic right ventricular cardiomyopathy (ARVC) and athlete's heart.

Full description

Comparison of the RV contractile reserve in 4 groups of patients: Arrhythmogenic right ventricular cardiomyopathy (ARVC) patients; endurance athletes with a dilated RV, endurance athletes with normal RV, untrained subject with normal RV.

Patients will come to the hospital for 3 visits (3 half days):

  • Visit 1: clinical evaluation, rest ECG, rest echocardiography, cardio-pulmonary exercise test.
  • Visit 2: exercise echocardiography, holter ECG monitor (48 yours)
  • Visit 3: rest CMR and exercise CMR (ergocycle)

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Men or women aged 18 years and older,

    • patients with confirmed ARVC, but with no major RV dysfunction (RVEF >40%)
    • endurance athletes with dilated RV
    • endurance athletes with non-dilated RV
    • untrained healthy subjects with non-dilated RV
  • who signed a written free and informed consent:

Exclusion criteria

  • Patients with other cardiovascular disease;
  • Contra-indication to CMR (in particular presence of a non-CMR compatible implantable cardiac defibrillator);
  • Patients with permanent supraventricular arrhythmia;
  • Patients unable to perform an exercise test on an ergocycle;
  • Person subject to legal protection (safeguard justice, trusteeship and guardianship) and persons deprived of liberty

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 4 patient groups

ARVC patients
Experimental group
Treatment:
Other: Cardiac exercises and tests
Endurance athletes with a dilated RV
Active Comparator group
Treatment:
Other: Cardiac exercises and tests
Endurance athletes with normal RV
Active Comparator group
Treatment:
Other: Cardiac exercises and tests
Untrained subject with normal RV
Experimental group
Treatment:
Other: Cardiac exercises and tests

Trial contacts and locations

1

Loading...

Central trial contact

Frédéric SCHNELL, MD-PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems